Clinical trial
Vitalis Study - Observational Study on the Quality of Life in Patients Under…
NCT00344825 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00344825 |
|---|---|
| Title | Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL) |
| Official title | Observational Study for Evaluation of Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia. |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Leukemia, B-Cell, Chronic |
| Intervention type | Drug |
| Interventions | Alemtuzumab (MabCampath, BAY86-5045) and Fludarabine Phosphate (Fludara, BAY86-4864) |
| Enrollment | 300 |
| Start date | Jan 1, 2004 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Jun 27, 2006 |
| Last update posted | Dec 4, 2013 |
| Countries | Italy |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: